Executive Board

Michael Scholl

CEO

Michael Scholl

Less information More information

Michael is CEO and Co-Founder of Leukocare, heading strategy, finance, corporate law, marketing & sales and HR. Before joining Leukocare, Michael was an entrepreneur and investor and founded several technology companies. He started his career as business consultant at BCG. Michael holds a master’s degree in business engineering from the University of Berlin.

Dr. Georg Dönges

CFO

Dr. Georg Dönges

Less information More information

Georg has spent more than 10 years in leading positions in the biotech industry & capital markets. He held various positions in a large finance org., eg. lead for restructuring of Corp. Finance at GfK SE, a KKR portfolio company. Previously, Georg worked at the Max-Planck-Institute of Biochemistry for his PhD thesis and earned the degree of a Certified International Investment Analyst (CIIA).

Dr. Cornelius Pompe

Dr. Cornelius Pompe

Chief Development Officer (CDO)

Less information More information

Cornelius brings more than 15 years of experience in early and late stage biopharmaceutical development. Before joining Leukocare, Cornelius served as Drug Product Development Head, Early Operations Lead and Member of the Process Development Senior Leadership Team at Amgen Research Munich/Micromet. Prior to his roles at Amgen/Micromet, he held several roles in the area of drug product development such as Head of Freeze-Dried Drug Product Development Unit at LFB (France) and Head of Formulation Development and Project Coordination at Coriolis. Cornelius holds a PhD in Pharmaceutical Technology from Ludwig Maximilians University Munich.

Dr. Dirk Winnemöller

Dr. Dirk Winnemöller

Chief Business Officer (CBO)

Less information More information

Dirk brings more than 14 years of experience in business operations and international marketing and sales in the biotechnology as well as biopharma industries to Leukocare. Before joining Leukocare, Dirk served as Global Vice President Business Development, Alliances and Organizational Strategy at Miltenyi Biomedicine GmbH. He was responsible for Business Development, Alliances/Partnering, Project Management, Communications, Organizational Strategy and Supply Chain. Prior to this role, Dirk held several commercial leadership positions including country manager DACH and Australia for Miltenyi Biotec. He holds a Dr. rer.nat from the Institute of Reconstructive Neurobiology, University of Bonn.

Dr. Sabine Hauck

Dr. Sabine Hauck

Executive Vice President, Corporate Development

Less information More information

Sabine brings 20 years of Drug Product development expertise as well as several years of in vitro diagnostic and biosensor development to Leukocare. Before joining Leukocare, Sabine was heading Pharmaceutical Development, QA and RA departments (Medigene, Acino, IDEA). She holds a Dr. rer. nat. from University of Regensburg.

Dr. Andreas Geissler

Dr. Andreas Geissler

Executive Vice President, IP and Legal

Less information More information

Andreas has been counseling pharmaceutical biotech companies on IP strategy for more than 15 years. He is a European and German Patent Attorney. Before joining Leukocare, Andreas served as Head of IP (Medigene) and attorney in private practice. He has in depth experience in IP strategy, portfolio management, patent prosecution, and FTO analysis. He holds a PhD in Molecular Cell Biology from Albert-Ludwigs-University Freiburg.